NO169125C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-substituerte 9-fluor-7-okso-2,3-dihydro-7h-pyrido(3.2.1-ij)-1,3,4-benzoksadiazin-6-karboksylsyrederivater - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-substituerte 9-fluor-7-okso-2,3-dihydro-7h-pyrido(3.2.1-ij)-1,3,4-benzoksadiazin-6-karboksylsyrederivaterInfo
- Publication number
- NO169125C NO169125C NO873816A NO873816A NO169125C NO 169125 C NO169125 C NO 169125C NO 873816 A NO873816 A NO 873816A NO 873816 A NO873816 A NO 873816A NO 169125 C NO169125 C NO 169125C
- Authority
- NO
- Norway
- Prior art keywords
- carboxylsyl
- benzoxadiazine
- pyrido
- fluor
- dihydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO894109A NO174926C (no) | 1986-09-12 | 1989-10-13 | Hydroksyamino-oksodihydrokinolinderivater |
| NO894108A NO171162C (no) | 1986-09-12 | 1989-10-13 | Pyrido-benzoksadiazinderivater |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP86112619 | 1986-09-12 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO873816D0 NO873816D0 (no) | 1987-09-11 |
| NO873816L NO873816L (no) | 1988-03-14 |
| NO169125B NO169125B (no) | 1992-02-03 |
| NO169125C true NO169125C (no) | 1992-05-13 |
Family
ID=8195410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO873816A NO169125C (no) | 1986-09-12 | 1987-09-11 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-substituerte 9-fluor-7-okso-2,3-dihydro-7h-pyrido(3.2.1-ij)-1,3,4-benzoksadiazin-6-karboksylsyrederivater |
Country Status (22)
| Country | Link |
|---|---|
| JP (3) | JPH0696578B2 (ja) |
| KR (1) | KR960002857B1 (ja) |
| CN (1) | CN1017800B (ja) |
| AT (1) | AT389119B (ja) |
| AU (1) | AU602534B2 (ja) |
| CA (1) | CA1336905C (ja) |
| CZ (1) | CZ281195B6 (ja) |
| DK (1) | DK173330B1 (ja) |
| DZ (1) | DZ1124A1 (ja) |
| FI (1) | FI86428C (ja) |
| HU (1) | HU199481B (ja) |
| IE (1) | IE61624B1 (ja) |
| IL (1) | IL83814A (ja) |
| MC (1) | MC1850A1 (ja) |
| MX (1) | MX8302A (ja) |
| NO (1) | NO169125C (ja) |
| NZ (1) | NZ221681A (ja) |
| PH (1) | PH23930A (ja) |
| PT (1) | PT85686B (ja) |
| SK (1) | SK278990B6 (ja) |
| ZA (1) | ZA876636B (ja) |
| ZW (1) | ZW16387A1 (ja) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZW16387A1 (en) * | 1986-09-12 | 1988-05-25 | Hoffmann La Roche | Tricyclic compounds |
| JP4820290B2 (ja) | 2004-05-13 | 2011-11-24 | 第一三共株式会社 | 置換ピロリジン誘導体 |
| US7563805B2 (en) * | 2005-05-19 | 2009-07-21 | Daiichi Pharmaceutical Co., Ltd. | Tri-, tetra-substituted-3-aminopyrrolidine derivative |
| AU2007225088B2 (en) | 2006-03-13 | 2012-09-13 | Kyorin Pharmaceutical Co., Ltd | Aminoquinolones as GSK-3 inhibitors |
| CA2699151A1 (en) | 2007-09-11 | 2009-03-19 | Activx Biosciences, Inc. | Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors |
| CA2699152C (en) | 2007-09-12 | 2015-11-24 | Activx Biosciences, Inc. | Spirocyclic aminoquinolones as gsk-3 inhibitors |
| FR2928150A1 (fr) * | 2008-02-29 | 2009-09-04 | Vetoquinol Sa Sa | Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens |
| EP2145891A1 (en) * | 2008-07-09 | 2010-01-20 | Vetoquinol S.A. | 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials |
| MX2011009414A (es) | 2009-03-11 | 2011-10-19 | Kyorin Seiyaku Kk | 7-cicloalquiloaminoquinolonas como inhibidores de gsk-3. |
| CN107522718B (zh) * | 2017-09-14 | 2019-11-08 | 浙江国邦药业有限公司 | 一种马波沙星的合成方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZW16387A1 (en) * | 1986-09-12 | 1988-05-25 | Hoffmann La Roche | Tricyclic compounds |
-
1987
- 1987-08-28 ZW ZW163/87A patent/ZW16387A1/xx unknown
- 1987-09-04 ZA ZA876636A patent/ZA876636B/xx unknown
- 1987-09-04 NZ NZ221681A patent/NZ221681A/en unknown
- 1987-09-07 IL IL83814A patent/IL83814A/xx not_active IP Right Cessation
- 1987-09-07 AU AU78114/87A patent/AU602534B2/en not_active Expired
- 1987-09-09 HU HU874007A patent/HU199481B/hu unknown
- 1987-09-09 DZ DZ870149A patent/DZ1124A1/fr active
- 1987-09-10 MC MC871911A patent/MC1850A1/xx unknown
- 1987-09-11 SK SK6604-87A patent/SK278990B6/sk unknown
- 1987-09-11 CZ CS876604A patent/CZ281195B6/cs not_active IP Right Cessation
- 1987-09-11 IE IE244487A patent/IE61624B1/en not_active IP Right Cessation
- 1987-09-11 CA CA000546674A patent/CA1336905C/en not_active Expired - Lifetime
- 1987-09-11 PT PT85686A patent/PT85686B/pt unknown
- 1987-09-11 KR KR1019870010082A patent/KR960002857B1/ko not_active IP Right Cessation
- 1987-09-11 DK DK198704772A patent/DK173330B1/da not_active IP Right Cessation
- 1987-09-11 NO NO873816A patent/NO169125C/no unknown
- 1987-09-11 FI FI873940A patent/FI86428C/fi not_active IP Right Cessation
- 1987-09-11 PH PH35800A patent/PH23930A/en unknown
- 1987-09-12 JP JP62227579A patent/JPH0696578B2/ja not_active Expired - Fee Related
- 1987-09-12 CN CN87106838A patent/CN1017800B/zh not_active Expired
- 1987-09-14 MX MX830287A patent/MX8302A/es unknown
- 1987-10-08 AT AT0263887A patent/AT389119B/de not_active IP Right Cessation
-
1994
- 1994-05-25 JP JP6133894A patent/JPH0826030B2/ja not_active Expired - Lifetime
- 1994-05-25 JP JP6133905A patent/JPH0819120B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO871277D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive oxadiazoler. | |
| NO871266L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
| NO870075L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater. | |
| NO166367C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno-1,4-diazepiner. | |
| NO870526L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater. | |
| NO880182D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater. | |
| NO904986D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater. | |
| NO874032D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater. | |
| NO874153D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater. | |
| NO167285C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive nafto(1,2-b)-1,4-tiazepinon-derivater. | |
| NO166281C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,1-disubstituerte cyklopropanderivater. | |
| NO165071C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-(3-amino-1-pyrrolidinyl)-8-klor-1-cyklopropyl-6- fluor-1,4,-dihydro-4-okso-3-kinolin-karboksylsyre. | |
| NO875488D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater. | |
| NO169125C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-substituerte 9-fluor-7-okso-2,3-dihydro-7h-pyrido(3.2.1-ij)-1,3,4-benzoksadiazin-6-karboksylsyrederivater | |
| NO873108D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-benzodiazepiner. | |
| NO165104C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1, 1-disubstituerte cyklopropanderivater. | |
| NO873680L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser. | |
| NO167146C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte diazepinoner. | |
| NO871766D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzo(de)isokinolin-1,3-dioner. | |
| NO881768D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner. | |
| NO165542C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner. | |
| NO168477C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte diazepinoner. | |
| NO166642C (no) | Anaolgifremgangsmaate for fremstilling av terapeutisk aktive 3-aryl-5-alkylthio-4h-1,2,4-triazoler. | |
| NO893768L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 2,7-diamino-1,2,3,4-tetrahydronaftalenderivater. | |
| NO874780D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater. |